By my sums, VRL is back within a normal leverage covenant range, with net debt roughly 3x my U EBITDA estimate. So bought some
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025